Intractable & Rare Diseases Research

Scope & Guideline

Pioneering Research in Rare Disease Solutions.

Introduction

Welcome to the Intractable & Rare Diseases Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Intractable & Rare Diseases Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2186-3644
PublisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINTRACTABLE RARE DIS / INTRACTABLE RARE DIS. RES.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO 00000, JAPAN

Aims and Scopes

The journal 'Intractable & Rare Diseases Research' focuses on the complex landscape of rare and intractable diseases, providing a platform for innovative research that addresses both clinical and scientific challenges. Its aim is to enhance understanding, diagnosis, and treatment of these conditions through rigorous analysis and interdisciplinary collaboration.
  1. Epidemiology of Rare Diseases:
    The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems.
  2. Genetic and Molecular Research:
    Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management.
  3. Clinical Management and Treatment Approaches:
    Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes.
  4. Patient-Centered Research:
    The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions.
  5. Innovative Technologies in Rare Disease Research:
    There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
The journal has identified and embraced several emerging themes that reflect the evolving landscape of rare disease research. These trends highlight areas of growing importance and potential impact on clinical practice and patient care.
  1. Integration of Artificial Intelligence in Rare Disease Research:
    A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine.
  2. Focus on Quality of Life and Patient Experiences:
    There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research.
  3. Innovations in Genetic Diagnostics:
    Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders.
  4. Interdisciplinary Collaborations:
    Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases.
  5. Emerging Treatments and Therapeutics:
    There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.

Declining or Waning

While the journal has seen a rich variety of themes over the years, certain areas appear to be declining in prominence. This may reflect shifts in research focus or advancements in knowledge and technology that have rendered some topics less critical.
  1. General Reviews of Rare Diseases:
    There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews.
  2. Historical Perspectives:
    Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions.
  3. Basic Science without Clinical Relevance:
    Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice.
  4. Epidemiological Studies in Developed Regions:
    There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.

Similar Journals

ORVOSI HETILAP

Advancing Knowledge, Shaping Practices
Publisher: AKADEMIAI KIADO ZRTISSN: 0030-6002Frequency: 52 issues/year

ORVOSI HETILAP is a pivotal journal in the field of general medicine, published by AKADEMIAI KIADO ZRT in Hungary. With its rich history dating back to 1949, this journal has been a platform for disseminating significant research findings and clinical advancements that impact healthcare practices. Although it currently falls within the Q4 category in the 2023 ranking of Medicine (miscellaneous), it holds a Scopus rank of #320 among 636 journals in its category, indicating its growing recognition among peers and scholars. The journal does not offer open access options, which may limit broader dissemination, but it nonetheless remains an important resource for medical professionals, researchers, and students engaging with contemporary medical issues. Located in the vibrant academic landscape of Budapest, ORVOSI HETILAP continues to contribute to the evolving dialogue in the medical community, showcasing diverse topics and fostering interdisciplinary collaboration.

Case Reports in Medicine

Empowering practitioners with evidence-based case insights.
Publisher: HINDAWI LTDISSN: 1687-9627Frequency: 1 issue/year

Case Reports in Medicine is a distinguished journal published by HINDAWI LTD, focusing on the vital field of medical case studies and reports. Since its inception in 2009, this Open Access journal has offered a platform for sharing novel insights, challenges, and outcomes encountered in clinical practice. Located in the United States, it serves a global audience of researchers and healthcare professionals, emphasizing the importance of case reports in advancing medical knowledge and promoting evidence-based practice. With an impressive ranking of Q3 in Medicine (miscellaneous) and a solid performance at #265/636 in General Medicine (58th percentile) as per Scopus, the journal is recognized for its impactful contributions to the medical community. Through its commitment to disseminating quality research, Case Reports in Medicine plays a crucial role in fostering collaboration and enhancing patient care worldwide, making it an essential resource for students, researchers, and practitioners alike.

KLINISCHE PADIATRIE

Transforming Pediatric Care with Cutting-Edge Discoveries
Publisher: GEORG THIEME VERLAG KGISSN: 0300-8630Frequency: 6 issues/year

KLINISCHE PADIATRIE is a prominent academic journal published by GEORG THIEME VERLAG KG since its inception in 1972. Based in Germany, this journal serves as a valuable resource for professionals and researchers in the fields of Pediatrics, Perinatology, and Child Health. With an ISSN of 0300-8630 and E-ISSN 1439-3824, it features a rich array of peer-reviewed articles that focus on child health and development, encompassing clinical practices, therapeutic advances, and interdisciplinary approaches to pediatric care. While the journal operates on a subscription basis, its impact within the academic community is evidenced by its ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, and it maintains a solid standing within Q4 in Medicine (miscellaneous). The journal aims to bridge the gap between emerging research and clinical practice, providing a platform for innovative ideas that enhance pediatric care. Researchers, medical professionals, and students alike will find KLINISCHE PADIATRIE an essential addition to their academic repertoire, fostering advancements in pediatric healthcare and enriching knowledge in this vital field.

Case Reports in Dermatology

Enhancing collaboration and education in dermatological research.
Publisher: KARGERISSN: 1662-6567Frequency: 3 issues/year

Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.

Clinical Medicine & Research

Connecting clinical practice with cutting-edge research.
Publisher: MARSHFIELD CLINICISSN: 1539-4182Frequency: 4 issues/year

Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.

International Journal of Clinical and Experimental Pathology

Empowering Pathology Through Open Access Research
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

SAGE Open Medical Case Reports

Transforming Case Reports into Global Learning
Publisher: SAGE PUBLICATIONS INCISSN: 2050-313XFrequency: 1 issue/year

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

Nature Reviews Disease Primers

Navigating the Complexities of Health and Disease
Publisher: NATURE PORTFOLIOISSN: 2056-676XFrequency: 1 issue/year

Nature Reviews Disease Primers, published by NATURE PORTFOLIO, stands as a leading journal in the field of Medicine, specifically recognized for its comprehensive coverage of various diseases and health-related topics. With an impressive impact factor that reflects its high citation rate, this journal is categorized within the Q1 quartile in Medicine (miscellaneous) and holds a prestigious Scopus rank of #4 out of 636, placing it in the 99th percentile of general medicine publications. Launched in 2015 and projected to continue its influence until 2024, the journal aims to bridge the gap between clinical research and practical application, providing easy-to-digest primers that summarize current understanding and emerging trends in various diseases. While not classified as open access, its rigorously peer-reviewed content remains crucial for academic researchers, healthcare professionals, and students alike, striving to stay at the forefront of medical knowledge. The journal's base in the United Kingdom enhances its global reach, contributing to the ongoing dialogue in the medical community.

IDCases

Exploring the frontiers of infectious disease research.
Publisher: ELSEVIER SCI LTDISSN: 2214-2509Frequency: 1 issue/year

Welcome to IDCases, a peer-reviewed open access journal published by Elsevier Science Ltd that has been at the forefront of infectious disease research since 2014. With a ISSN of 2214-2509, IDCases is dedicated to the publication of high-quality case reports and novel findings in the field of infectious diseases, aiming to enhance clinical practice and guide therapeutic decision-making. Positioned in the Q3 Quartile of the infectious diseases category, and ranked #213 out of 344 in Scopus’s Medicine _ Infectious Diseases category, the journal establishes essential connections between academia and the healthcare community. As an open access journal, IDCases ensures that critical research is disseminated widely, fostering collaboration and innovation in managing infectious diseases. By encouraging submissions that explore both common and rare infections, global outbreaks, and novel therapeutic approaches, IDCases serves as a critical resource for researchers, healthcare professionals, and students alike. Join us in advancing the discourse and understanding of infectious diseases!

BMJ Case Reports

Exploring Uncommon Cases to Transform Patient Outcomes
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.